Results from an interim analysis in the Phase 2 STARBORN-1 trial of TARA-002 in pediatric LMs patients remain on track for 4Q ...
Venture Global, Inc. (NYSE: VG) has reported financial results for the quarter ended September 30, 2025.
ABC News' Katherine Faulders and Karen Travers report on the latest developments in the Trump administration's handling of the Epstein files. The White House on Thursday announced framework deals with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback